Correlation Between Silo Pharma and Axim Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Axim Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Axim Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silo Pharma and Axim Biotechnologies, you can compare the effects of market volatilities on Silo Pharma and Axim Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Axim Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Axim Biotechnologies.

Diversification Opportunities for Silo Pharma and Axim Biotechnologies

0.46
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Silo and Axim is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Axim Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axim Biotechnologies and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Axim Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axim Biotechnologies has no effect on the direction of Silo Pharma i.e., Silo Pharma and Axim Biotechnologies go up and down completely randomly.

Pair Corralation between Silo Pharma and Axim Biotechnologies

Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Axim Biotechnologies. But the otc stock apears to be less risky and, when comparing its historical volatility, Silo Pharma is 3.75 times less risky than Axim Biotechnologies. The otc stock trades about -0.17 of its potential returns per unit of risk. The Axim Biotechnologies is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest  0.50  in Axim Biotechnologies on August 31, 2024 and sell it today you would lose (0.20) from holding Axim Biotechnologies or give up 40.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Silo Pharma  vs.  Axim Biotechnologies

 Performance 
       Timeline  
Silo Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Axim Biotechnologies 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Axim Biotechnologies are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile forward indicators, Axim Biotechnologies displayed solid returns over the last few months and may actually be approaching a breakup point.

Silo Pharma and Axim Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Silo Pharma and Axim Biotechnologies

The main advantage of trading using opposite Silo Pharma and Axim Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Axim Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axim Biotechnologies will offset losses from the drop in Axim Biotechnologies' long position.
The idea behind Silo Pharma and Axim Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine